JG
SPPI

Joel Greenblatt’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Joel Greenblatt’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-39,070
Closed -$257K – 1077
2016
Q2 		$257K Buy
+39,070
New +$276K ﹤0.01% 840

Other funds holding SPPI

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Joel Greenblatt's SPPI Position: Q3 2016 in Review

Joel Greenblatt sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2016, closing a stake of 39,070 shares — an estimated $257K sold.

Joel Greenblatt first reported a position in SPPI in Q2 2016 and held it in 1 quarter. The position peaked at $257K in Q2 2016. 144 funds tracked by Wall St. Rank hold SPPI as of Q3 2016.

  • Joel Greenblatt reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2016 after selling out during the quarter.
  • Joel Greenblatt sold 39,070 Spectrum Pharmaceuticals Inc shares in Q3 2016, an estimated $257K.
  • Joel Greenblatt first reported a position in Spectrum Pharmaceuticals Inc in Q2 2016 and held it in 1 quarter.
  • Joel Greenblatt's Spectrum Pharmaceuticals Inc position peaked at $257K in Q2 2016.
  • 144 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2016.

Based on Gotham Asset Management's 13F filing for Q3 2016, filed 14 Nov 2016.